SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001728117-24-000052
Filing Date
2024-05-06
Accepted
2024-05-06 07:31:01
Documents
15
Period of Report
2024-05-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K goss-20240503.htm   iXBRL 8-K 44098
2 EX-99.1 goss-20240506xexx991.htm EX-99.1 23026
6 GRAPHIC gossamerbio-logoxreg.jpg GRAPHIC 150783
  Complete submission text file 0001728117-24-000052.txt   409372

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20240503.xsd EX-101.SCH 1913
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20240503_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20240503_pre.xml EX-101.PRE 12516
18 EXTRACTED XBRL INSTANCE DOCUMENT goss-20240503_htm.xml XML 2716
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 24915583
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)